arrow
S

Stefania Scala

istituto nazionale tumori irccs fondazione g. pascale
H指数:49
被引数:7,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CXCR4+ circulating tumor cells (CTCs) accumulate in subcutaneous, immune suppressive, CXCL12-loaded-hydrogel

CXCR4+循环肿瘤细胞(CTCs)在皮下、免疫抑制性、CXCL12负载水凝胶中积累

2026-09-040
OAAI
CXCR4, CXCR7 and PBRM1 are responsible for everolimus and cabozantinib resistance in human renal cancer cells

CXCR4、CXCR7和PBRM1是人类肾癌细胞中依维莫司和卡博赞尼耐药性的相关因素。

2026-03-280
OAAI
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin plus paclitaxel/avelumab (MITO-END3 trial)

外周单核细胞源性抑制性细胞与单中心接受卡铂联合紫杉醇/阿维单抗治疗子宫内膜癌患者分子亚型的相关性(MITO-END3试验)

2025-04-170
OA
Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification
2024-12-010
PRE
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites
2024-10-011
PRE
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization
HELIYON
IF3.6
2024-08-010
OAAI
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
2024-05-042
OA
CXCL12-loaded-hydrogel (CLG) in vivo modifies lung metastatic niche toward an immunoactive microenvironment reducing lung metastasis development
2024-03-220
PRE
Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study

来自胃肠道的寡转移肿瘤: 临床和分子驱动因素的鉴定: 预测研究

2023-10-190
OAAI
Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4Leu317fsX3 mutation causing WHIM syndrome
2023-03-088
OA